ArticleCureus2025
Recurrent Beta-Human Chorionic Gonadotropin (β-hCG) Elevation and Suspicion of Gestational Trophoblastic Neoplasia Following a Complete Hydatidiform Mole in a 17-Year-Old Female Patient: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The patients with complete hydatidiform mole (CHM) often present with markedly elevated beta-human chorionic gonadotropin (β-hCG) levels, uterine enlargement, and trophoblastic hyperplasia, and may develop complications such as preeclampsia, hyperthyroidism, or theca lutein cysts. The risk of developing persistent gestational trophoblastic neoplasia (GTN) following CHM is substantially higher than with partial hydatidiform mole (PHM). We describe the case of a 17-year-old female patient referred for evaluation of abdominal distension, abnormal vaginal bleeding, and hypertension. Imaging and laboratory findings suggested a molar pregnancy. She underwent repeat uterine evacuations and received methotrexate therapy. Histopathological examination confirmed a CHM. Serial monitoring initially demonstrated a decline in β-hCG, but subsequent fluctuations and recurrent vaginal bleeding raised suspicion for post-molar GTN. The additional histological findings raised the possibility of an epithelioid trophoblastic tumor. Following several cycles, β-hCG levels steadily declined and eventually normalized. This case highlights the diagnostic and therapeutic challenges of molar pregnancy in adolescents. It underscores the importance of β-hCG surveillance, timely initiation of chemotherapy when regression fails, and careful histopathological evaluation. Early recognition and individualized management can prevent complications and improve outcomes in young patients at risk of post-molar GTN.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.